Lipid parameters but not inflammatory indices predict hepatitis B vaccine responses in hemodialysis patients

Clicks: 2
ID: 319223
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #65 of 127 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 127 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Hepatitis B virus (HBV) vaccination is essential in hemodialysis (HD) populations, yet seroprotection remains suboptimal. Inflammation-related hematologic indices are frequently used in clinical practice, but their ability to predict HBV vaccine response in HD patients is uncertain. We evaluated clinical and laboratory determinants of HBV vaccine response, with a focus on lipid-derived indices and inflammatory ratios. Methods In this multicenter retrospective study, adult HD patients followed between 2015 and 2025 who received at least three doses of HBV vaccine and had available anti-HBs measurements were included (n = 341). Vaccine response was defined as anti-HBs ≥ 10 IU/L; non-response as < 10 IU/L. Neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte (PLR), monocyte-to-lymphocyte (MLR), neutrophil percentage-to-albumin ratio (NPAR), and lipid ratios (TG/HDL, TC/HDL, LDL/HDL) were calculated. Additional analyses using percentile-based categorization of NPAR confirmed the absence of a significant association with vaccine response. Multivariable logistic regression and receiver operating characteristic analyses were performed. Results After the primary vaccination series, seroprotection was 77.4% and increased to 88.6% after revaccination/boosters; it declined to 78.3% at 1 year and 69.2% at 2 years. Non-responders were older and had higher triglyceride levels and lower HDL cholesterol levels. In contrast, inflammatory indices (NLR, PLR, MLR, and NPAR) did not differ significantly between groups. These indices also demonstrated limited discriminative ability for predicting vaccine response. In multivariable analysis, HDL cholesterol remained positively associated with vaccine response (OR: 1.046, 95% CI: 1.006–1.086, P = 0.022), and triglyceride levels were negatively associated with vaccine response (OR: 0.992, 95% CI: 0.984–0.999, P = 0.024). The TG/HDL ratio showed borderline statistical significance (OR: 1.235, 95% CI: 0.983–1.551, P = 0.070), suggesting a potential but limited contribution to vaccine response prediction. Conclusions In HD patients, hematologic inflammatory indices were not informative for HBV vaccine response, whereas an atherogenic lipid profile—particularly lower HDL and higher triglycerides—showed a consistent association. Lipid parameters may support risk stratification and tailored post-vaccination monitoring strategies.
Reference Key
openalex_W7166808436 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Himmet EKİCİ, Arzu Mirza, Sevgi Baltacı, Davut Eren, Feyza İzci Çetinkaya, Mehmet Ceylan, Cansel Dağdelen, Sümeyye Yeşildağ, Sümeyra Koyuncu
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag221
URL
https://doi.org/10.1093/ckj/sfag221
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.